Search - tctmd.com

Displaying 941 - 960 of 2119

Sort: Relevancy | Date

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Daily News

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Michael O'Riordan

June 22, 2017

News Daily News

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Caitlin E. Cox

June 21, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

News Daily News

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Yael L. Maxwell

June 16, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

News Conference News EuroPCR 2017

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Yael L. Maxwell

May 22, 2017

News Conference News EuroPCR 2017

Slimmest Stent to Date Looks Promising in Small Study

Shelley Wood

May 19, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Industry News

Boston Scientific Closes Symetis Acquisition

May 16, 2017

News Conference News EuroPCR 2017

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

Caitlin E. Cox

May 16, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Conference News SCAI 2017

Domo Arigato: High Success Rates, Low Radiation With Both Radial and Femoral Robotic PCI

L.A. McKeown

May 12, 2017

News Daily News

Masters Athletes at Low Risk for CAD Seem to Develop Atherosclerosis Differently, Study Suggests

Caitlin E. Cox

May 08, 2017

Advertisement

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Slimmest Stent to Date Looks Promising in Small Study

More Early Stroke With SAVR Than TAVR in SURTAVI

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Boston Scientific Closes Symetis Acquisition

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

Domo Arigato: High Success Rates, Low Radiation With Both Radial and Femoral Robotic PCI

Masters Athletes at Low Risk for CAD Seem to Develop Atherosclerosis Differently, Study Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content